Cue Biopharma Correlations

CUE Stock

USD 1.02 0.01 0.97%

The current 90-days correlation between Cue Biopharma and Coya Therapeutics, Common is 0.25 (i.e., Modest diversification). The correlation of Cue Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Cue Biopharma Correlation With Market

Significant diversification

The correlation between Cue Biopharma and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cue Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For information on how to trade Cue Stock refer to our How to Trade Cue Stock guide.

Moving together with Cue Stock

0.7	KZR	Kezar Life Sciences	Pair Corr
0.81	MLYS	Mineralys Therapeutics,	Pair Corr
0.66	KB	KB Financial Group	Pair Corr
0.68	HPQ	HP Inc	Pair Corr
0.64	BAC	Bank of America Fiscal Year End 10th of January 2025	Pair Corr
0.73	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr

Moving against Cue Stock

0.79	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.75	NKTX	Nkarta Inc	Pair Corr
0.74	MTEM	Molecular Templates	Pair Corr
0.67	TPST	Tempest Therapeutics	Pair Corr
0.66	AGL	agilon health	Pair Corr
0.65	ME	23Andme Holding	Pair Corr
0.57	IPSC	Century Therapeutics	Pair Corr
0.56	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.55	CYRX	Cryoport	Pair Corr
0.51	VALN	Valneva SE ADR	Pair Corr
0.42	A	Agilent Technologies Earnings Call This Week	Pair Corr
0.4	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.4	BACK	IMAC Holdings	Pair Corr
0.31	ROIV	Roivant Sciences	Pair Corr
0.8	EC	Ecopetrol SA ADR	Pair Corr
0.74	PG	Procter Gamble	Pair Corr
0.73	KO	Coca Cola Aggressive Push	Pair Corr
0.72	TLK	Telkom Indonesia Tbk	Pair Corr
0.66	HYMTF	Hyundai Motor	Pair Corr
0.6	SHG	Shinhan Financial	Pair Corr
0.48	WF	Woori Financial Group	Pair Corr
0.45	BA	Boeing Fiscal Year End 29th of January 2025	Pair Corr
0.38	VFSWW	VinFast Auto	Pair Corr

Related Correlations Analysis

	COYA	LTRN	FENC	ELYM	ANIX	INMB	INAB	PYPD	XFOR	GRTX
COYA		-0.32	-0.51	-0.4	0.01	-0.23	-0.3	-0.31	-0.4	-0.03	COYA
LTRN	-0.32		0.64	0.58	0.13	0.48	0.51	0.31	0.76	0.02	LTRN
FENC	-0.51	0.64		0.69	0.18	0.53	0.59	0.17	0.69	-0.02	FENC
ELYM	-0.4	0.58	0.69		0.03	0.18	0.17	0.12	0.77	0.43	ELYM
ANIX	0.01	0.13	0.18	0.03		0.51	0.16	-0.1	0.23	-0.3	ANIX
INMB	-0.23	0.48	0.53	0.18	0.51		0.64	-0.1	0.5	-0.35	INMB
INAB	-0.3	0.51	0.59	0.17	0.16	0.64		0.05	0.36	-0.51	INAB
PYPD	-0.31	0.31	0.17	0.12	-0.1	-0.1	0.05		0.17	-0.06	PYPD
XFOR	-0.4	0.76	0.69	0.77	0.23	0.5	0.36	0.17		0.27	XFOR
GRTX	-0.03	0.02	-0.02	0.43	-0.3	-0.35	-0.51	-0.06	0.27		GRTX
	COYA	LTRN	FENC	ELYM	ANIX	INMB	INAB	PYPD	XFOR	GRTX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

XFOR	+ 0.77	ELYM
XFOR	+ 0.76	LTRN
ELYM	+ 0.69	FENC
XFOR	+ 0.69	FENC
FENC	+ 0.64	LTRN
INAB	+ 0.64	INMB

High negative correlations

GRTX	- 0.51	INAB
FENC	- 0.51	COYA
XFOR	- 0.4	COYA
ELYM	- 0.4	COYA
GRTX	- 0.35	INMB
LTRN	- 0.32	COYA

Risk-Adjusted Indicators

There is a big difference between Cue Stock performing well and Cue Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cue Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
COYA	3.81	0.02	0.02	0.13	5.76	(4.43)	8.56	(7.20)	44.12
LTRN	3.36	(0.64)	0.00	(0.18)	0.00	0.00	9.58	(6.88)	23.02
FENC	3.11	(0.17)	(0.02)	0.02	3.83	(3.57)	7.14	(6.68)	23.48
ELYM	3.92	(0.95)	0.00	(5.36)	0.00	0.00	6.21	(9.35)	34.87
ANIX	2.71	0.00	(0.01)	0.12	3.14	(3.30)	6.29	(5.74)	31.27
INMB	3.39	(0.63)	0.00	(0.14)	0.00	0.00	5.78	(7.10)	22.66
INAB	5.43	0.02	0.00	0.11	0.00	0.00	6.67	(11.54)	109.03
PYPD	2.49	(0.02)	(0.01)	0.10	3.17	(3.03)	5.47	(4.97)	23.57
XFOR	4.97	(0.84)	0.00	(0.45)	0.00	0.00	6.90	(10.61)	62.35
GRTX	2.93	0.05	0.00	0.04	0.00	0.00	7.31	(5.84)	18.16

Cue Biopharma Corporate Management

JD MSc	CEO Director	Profile
Kenneth MD	Acting Officer	Profile
Steven Almo	CoFounder Board	Profile
Matteo MD	Chief Officer	Profile
Dr III	CoFounder	Profile
Lucinda Warren	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC